oxybutynin has been researched along with Premenstrual Syndrome in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One study compared patch dosage (100 vs 200 µg oestrogen, with progestogen in both arms) and had a high risk of performance bias, detection bias and attrition bias." | 2.55 | Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome. ( Kuiper, JH; Naheed, B; O'Brien, PM; O'Mahony, F; Uthman, OA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naheed, B | 1 |
| Kuiper, JH | 1 |
| Uthman, OA | 1 |
| O'Mahony, F | 1 |
| O'Brien, PM | 1 |
1 review available for oxybutynin and Premenstrual Syndrome
| Article | Year |
|---|---|
Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
Topics: Administration, Oral; Drug Implants; Drug Therapy, Combination; Estrogens; Female; Humans; Luteal Ph | 2017 |